These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25256510)

  • 21. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
    Tran TT; Tran PH; Lee BJ
    Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution-state polymer assemblies influence BCS class II drug dissolution and supersaturation maintenance.
    Dalsin MC; Tale S; Reineke TM
    Biomacromolecules; 2014 Feb; 15(2):500-11. PubMed ID: 24328187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic Design of Chemically Diverse Polymers with Applications in Oral Drug Delivery.
    Mosquera-Giraldo LI; Borca CH; Meng X; Edgar KJ; Slipchenko LV; Taylor LS
    Biomacromolecules; 2016 Nov; 17(11):3659-3671. PubMed ID: 27715018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H; Handa T; Alonzo DE; Taylor LS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperbranched double hydrophilic block copolymer micelles of poly(ethylene oxide) and polyglycerol for pH-responsive drug delivery.
    Lee S; Saito K; Lee HR; Lee MJ; Shibasaki Y; Oishi Y; Kim BS
    Biomacromolecules; 2012 Apr; 13(4):1190-6. PubMed ID: 22414172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems.
    Gupta B; Mishra V; Gharat S; Momin M; Omri A
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.
    Li S; Liu Y; Liu T; Zhao L; Zhao J; Feng N
    Int J Pharm; 2011 Jun; 411(1-2):172-7. PubMed ID: 21511016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state.
    Shi NQ; Yao J; Wang XL
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1112-22. PubMed ID: 23808528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of ethylene glycol substituted poly(phenylene vinylene) derivatives.
    Wang CC; Tsai H; Shih HH; Jeon S; Xu Z; Williams D; Iyer S; Sanchez TC; Wang L; Cotlet M; Wang HL
    ACS Appl Mater Interfaces; 2010 Mar; 2(3):738-47. PubMed ID: 20356275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization.
    Sant VP; Smith D; Leroux JC
    J Control Release; 2004 Jun; 97(2):301-12. PubMed ID: 15196757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.